Evidence map›Paper›PMID 26374122›Full record

ArticlemBio2015

The Human Skin Microbiome Associates with the Outcome of and Is Influenced by Bacterial Infection.

Julia J van Rensburg, Huaiying Lin, Xiang Gao, Evelyn Toh, Kate R Fortney, Sheila Ellinger, Beth Zwickl, Diane M Janowicz, Barry P Katz, David E Nelson and 2 more

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05750381 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

TypeinterventionalSponsorBLIS Technologies LimitedRan2023 to 2023Enrolled20ConditionsMicrobial ColonizationArmsMicrococcus luteus Blis Q24 balm, Placebo balm
NCT06137209 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Serum in Healthy Adults

TypeinterventionalSponsorBLIS Technologies LimitedRan2023 to 2024Enrolled20ConditionsMicrobial ColonizationArmsActive Comparator: Study Group A: Blis Q24 Serum at higher dose, Active Comparator: Study Group B: Blis Q24 Serum at lower dose
NCT06166979 nacompletednot on this mapstarted 2024, after this paper: background citation

Assessment of Colonization and Scalp Quality Parameter Improvement by Topical Application of Probiotic Micrococcus Luteus Q24 in Healthy Adults.

TypeinterventionalSponsorBLIS Technologies LimitedRan2024 to 2024Enrolled20ConditionsMicrobial ColonizationArmsActive Comparator: Study Group A: Blis Q24 Serum at higher dose, Active Comparator: Study Group B: Blis Q24 Serum at lower dose
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Julia J van RensburgDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Huaiying LinDepartment of Public Health Sciences, Center for Biomedical Informatics, Loyola University Chicago, Maywood, Illinois, USA.
Xiang GaoDepartment of Public Health Sciences, Center for Biomedical Informatics, Loyola University Chicago, Maywood, Illinois, USA.
Evelyn TohDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kate R FortneyDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Sheila EllingerDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Beth ZwicklDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Diane M JanowiczDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Barry P KatzDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Biostatistics, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
David E NelsonDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Qunfeng DongDepartment of Public Health Sciences, Center for Biomedical Informatics, Loyola University Chicago, Maywood, Illinois, USA.
Stanley M SpinolaDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA Center for Immunobiology, Indiana University School of Medicine, Indianapolis, Indiana, USA sspinola@iu.edu.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineLoyola University Chicago · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
VIRAL DETERMINANTS OF HSV DISEASE IN MICEU19AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI OTT, MARY A. · 1995 to 2009
$13.6M
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR01AI027863 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SPINOLA, STANLEY M. · 1995 to 2013
$3.8M
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR29AI027863 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SPINOLA, STANLEY M · 1990 to 1994
–
NCATS NIH HHS UL1 TR001108NCRR NIH HHS UL RR052761NIAID NIH HHS AI27863S1NIAID NIH HHS R01 AI027863NIAID NIH HHS U19 AI031494NIAID NIH HHS U19 AI3149
6 · The paper itself

Abstract

unlabelledThe influence of the skin microbiota on host susceptibility to infectious agents is largely unexplored. The skin harbors diverse bacterial species that may promote or antagonize the growth of an invading pathogen. We developed a human infection model for Haemophilus ducreyi in which human volunteers are inoculated on the upper arm. After inoculation, papules form and either spontaneously resolve or progress to pustules. To examine the role of the skin microbiota in the outcome of H. ducreyi infection, we analyzed the microbiomes of four dose-matched pairs of "resolvers" and "pustule formers" whose inoculation sites were swabbed at multiple time points. Bacteria present on the skin were identified by amplification and pyrosequencing of 16S rRNA genes. Nonmetric multidimensional scaling (NMDS) using Bray-Curtis dissimilarity between the preinfection microbiomes of infected sites showed that sites from the same volunteer clustered together and that pustule formers segregated from resolvers (P = 0.001, permutational multivariate analysis of variance [PERMANOVA]), suggesting that the preinfection microbiomes were associated with outcome. NMDS using Bray-Curtis dissimilarity of the endpoint samples showed that the pustule sites clustered together and were significantly different than the resolved sites (P = 0.001, PERMANOVA), suggesting that the microbiomes at the endpoint differed between the two groups. In addition to H. ducreyi, pustule-forming sites had a greater abundance of Proteobacteria, Bacteroidetes, Micrococcus, Corynebacterium, Paracoccus, and Staphylococcus species, whereas resolved sites had higher levels of Actinobacteria and Propionibacterium species. These results suggest that at baseline, resolvers and pustule formers have distinct skin bacterial communities which change in response to infection and the resultant immune response. IMPORTANCE: Human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome. Some resident bacteria are thought to protect the skin from infection by outcompeting pathogens for resources or by priming the immune system's response to invaders. However, the influence of the skin microbiome on the susceptibility to or protection from infection has not been prospectively evaluated in humans. We characterized the skin microbiome before, during, and after experimental inoculation of the arm with Haemophilus ducreyi in matched volunteers who subsequently resolved the infection or formed abscesses. Our results suggest that the preinfection microbiomes of pustule formers and resolvers have distinct community structures which change in response to the progression of H. ducreyi infection to abscess formation.

Indexed as

MicrobiotaCluster AnalysisDNA, BacterialDNA, RibosomalHaemophilus ducreyiHumansMolecular Sequence DataPhylogenyProspective StudiesRNA, Ribosomal, 16SSequence Analysis, DNASkinSkin Diseases, BacterialDNA, BacterialDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

PMID26374122
PMCPMC4600114
OpenAlexW2145625348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.